Imodium Plus

Dimeticone and Loperamide Hydrochloride, the active ingredients in Imodium Plus, are an anti‑foaming agent and an opioid receptor agonist presented as an oral formulation for over‑the‑counter use. It provides symptomatic relief of acute diarrhea, travelers' diarrhea and abdominal gas in adults and children.

GNH USA supplies Imodium Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Plus acts on intestinal motility and gas formation to treat common gastrointestinal disturbances. - Acute nonspecific diarrhea: reduces stool frequency and improves consistency. - Travelers' diarrhea: offers rapid symptom control for individuals on short‑term trips. - Abdominal bloating and gas: alleviates discomfort by decreasing gas bubbles in the gut.

Adverse reactions may occur with Imodium Plus and should be monitored.

Common Side Effects: - Constipation: reduced bowel movements. - Nausea: mild stomach upset. - Abdominal cramps: intermittent discomfort. - Dry mouth: reduced salivation. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Severe constipation or ileus: risk of bowel obstruction. - Allergic reactions: rash, itching, swelling. - Cardiac arrhythmia: especially with concomitant CYP3A4 inhibitors. - Toxic megacolon: rare but life‑threatening colonic dilation. - Persistent vomiting: may indicate toxicity.

Use Imodium Plus with care and observe the following precautions. - Do not exceed recommended dose: follow prescriber or label instructions. - Caution in hepatic impairment: reduced metabolism may increase drug levels. - Avoid in bacterial enterocolitis: may worsen infection. - Not for children under 2 years: safety not established. - Seek medical advice if symptoms persist beyond 48 hours. - Store below 25°C: keep in the original pack, protect from moisture.

Imodium Plus can interact with other medicines; consider the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise loperamide plasma concentrations. - QT‑prolonging agents (e.g., quinidine, sotalol): increase risk of cardiac arrhythmia. - Other antidiarrheal agents: additive effect on gut motility.

Moderate Interactions (Monitor Closely): - Opioid analgesics: may enhance central opioid effects. - Anticholinergic drugs: could intensify constipation. - Antacids containing aluminum or magnesium: may affect absorption of loperamide.